GHK‑Cu 100mg | ≥99% Purity Research Peptide

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of GHK-Cu supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF-GHK100-B241

Key analytical results include:

• Assay Content: 93.2 mg
• Identification – Retention Time: 0.992
• Identification – Spectrum: 999
• Purity: 99.6 percent
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

GHK-Cu is a copper-binding tripeptide complex frequently studied in controlled laboratory environments investigating cellular signalling, tissue remodelling and biochemical regulatory pathways.

The compound consists of the naturally occurring tripeptide glycyl-L-histidyl-L-lysine (GHK) bound to a copper ion, forming a stable peptide–metal complex used in biochemical and cellular research.

This preparation contains 100 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves molecular stability and allows researchers to reconstitute the compound for controlled in vitro experimentation.

Due to its well-characterised biochemical structure and reproducible analytical profile, GHK-Cu has become a widely referenced peptide complex in experimental cellular signalling and tissue biology research models.

Compound Overview

GHK-Cu, commonly referred to as copper tripeptide-1, is a naturally derived peptide complex consisting of the tripeptide GHK bound to copper ions.

In biochemical research, copper-binding peptides are investigated for their interaction with cellular regulatory pathways involved in extracellular matrix signalling and cellular communication.

GHK-Cu has been used in experimental models examining peptide-mediated signalling mechanisms, cellular regulatory responses and protein expression pathways.

These studies allow researchers to investigate how peptide–metal complexes participate in biochemical signalling networks and cellular regulatory systems.

Historical Background and Scientific Context

Scientific interest in GHK-Cu originated during the 1970s when researchers first identified the tripeptide glycyl-histidyl-lysine in human plasma.

Subsequent research demonstrated that this peptide naturally binds copper ions to form a biologically active complex.

As molecular biology techniques advanced, scientists began investigating the role of copper-binding peptides in cellular signalling and tissue remodelling processes.

Over time, GHK-Cu became a commonly referenced compound in experimental models studying extracellular matrix signalling, protein expression regulation and cellular communication pathways.

Mechanistic Focus in Research

Within experimental laboratory environments, GHK-Cu is commonly studied in relation to cellular regulatory pathways and peptide-mediated signalling systems.

Research investigations frequently explore the compound in experimental models examining:

• Copper-binding peptide signalling pathways
• Extracellular matrix regulatory mechanisms
• Cellular protein expression modulation
• Tissue remodelling signalling networks
• Peptide-mediated biochemical communication
• Comparative peptide complex research
• Cellular regulatory pathway modelling

These experimental models allow scientists to investigate molecular signalling processes involved in cellular regulation and tissue biology.

Research Applications

In controlled research environments, GHK-Cu may be utilised in experimental models designed to explore peptide signalling and cellular regulatory systems.

Examples of research applications include:

• Cell signalling pathway research
• Extracellular matrix biology studies
• Peptide-mediated regulatory pathway analysis
• Comparative peptide complex evaluation
• Protein expression signalling research
• Cellular communication pathway modelling
• Controlled in vitro biochemical studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

Independently verified by Liquilabs s.r.o. (Czechia)
Validated assay content 93.2 mg
Confirmed purity 99.6 percent
Retention time and spectral identity confirmation
Endotoxin levels below 0.001 EU per mg
No detectable microbial contamination
No detectable heavy metals
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.